Last reviewed · How we verify
NCT04499768
A Longitudinal Study of Choroidal Changes After Cataract Surgery in Eyes With Diabetic Retinopathy
trial in Optical Coherence Tomography in 46 participants. Status unknown.
30 October 2019
Quick facts
| Lead sponsor | Ruijin Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 46 |
| Start date | 1 June 2018 |
| Primary completion | 30 October 2019 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across China |
Conditions studied
- Optical Coherence Tomography — all drugs for Optical Coherence Tomography →
- Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
- Choroid — all drugs for Choroid →
Sponsor
Ruijin Hospital
Who can join
Adults 40 to 80, any sex, with Optical Coherence Tomography or Diabetic Retinopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine the influence of phacoemulsification on choroidal vasculature in patients with diabetic retinopathy (DR) undergoing cataract surgery
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Choroidal Structural Changes Assessed with Swept-Source Optical Coherence Tomography after Cataract Surgery in Eyes with Diabetic Retinopathy.
Yao H, Gao S, Liu X, Zhou Y, et al · · 2020 · cited 9× · PMID 33178452 · DOI 10.1155/2020/5839837
Verify or expand the search:
- PubMed search for NCT04499768
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Optical Coherence Tomography
Currently open trials in the same condition.
- NCT06040073 — Natural History of Coronary Atherosclerosis · recruiting
- NCT06520904 — Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography · Phase 4 · recruiting
- NCT06436482 — Research of Endobronchial Optical Coherence Tomography in Pre-COPD · recruiting
- NCT05340361 — Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT · recruiting
- NCT05230446 — PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlus · NA · recruiting
Other Ruijin Hospital trials
Trials by the same sponsor.
- NCT07589361 — Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · not yet recruiting
- NCT07449507 — Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy · NA · not yet recruiting
- NCT07496385 — Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound · NA · not yet recruiting
- NCT07511114 — A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyp · Phase 3 · not yet recruiting
- NCT07514169 — The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04499768 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ruijin Hospital
- Last refreshed: 5 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04499768.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing